29 Organizations Achieve Excellence in Respiratory Care
February 16, 2023 16:00 ET
|
American Association for Respiratory Care - Irving, TX
Irving, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The American Association for Respiratory Care (AARC) has named 29 organizations from across the U.S. as recipients of the 2023-2024 Apex Recognition Award....
US Med-Equip partners with Turn Medical to help hospitals gain on-demand access to new automated prone therapy bed for critically ill respiratory patients
January 24, 2023 08:01 ET
|
US Med-Equip
HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- As healthcare professionals continue to battle COVID, the flu, and other respiratory illnesses, hospitals nationwide are gaining on-demand access to...
Global Digital Therapeutics Market Projected to Surpass $12,695.60 Million, Growing at 20.0% CAGR in the 2021–2028 Timeframe [175-Pages] | Reasoning by Research Dive
January 02, 2023 09:01 ET
|
Research Dive
New York, USA, Jan. 02, 2023 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global digital therapeutics market. As per the report, the market is projected to hit $12,695.60...
Global Anesthesia and Respiratory Devices Market will reach to USD 74 billion by 2029 : GreyViews
December 22, 2022 12:00 ET
|
GreyViews
Pune India, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East...
Extracorporeal Membrane Oxygenation Market to hit USD 639 Million by 2032, says Global Market Insights Inc.
December 12, 2022 06:10 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Dec. 12, 2022 (GLOBE NEWSWIRE) -- The extracorporeal membrane oxygenation market value is set to reach USD 639 million by 2032, according to a new research report by Global...
爱科百发宣布呼吸道合胞病毒新药爱司韦®的上市许可申请获国家药品监督管理局正式受理并纳入优先审评审批程序
December 08, 2022 20:00 ET
|
Shanghai Ark Biopharmaceutical Co., Ltd.
中国上海, Dec. 09, 2022 (GLOBE NEWSWIRE) -- 上海爱科百发生物医药技术股份有限公司（以下简称“ 爱科百发”），一家致力于儿科及呼吸疾病领域创新药研发的生物制药企业，今日宣布中国国家药品监督管理局正式受理治疗呼吸道合胞病毒（RSV）感染新药爱司韦®（通用名：齐瑞索韦/ziresovir）的上市许可申请（NDA），并且纳入“优先审评审批”程序。 ...
愛科百發宣佈呼吸道合胞病毒新藥愛司韋®的上市許可申請獲國家藥品監督管理局正式受理並納入優先審評審批程式
December 08, 2022 20:00 ET
|
Shanghai Ark Biopharmaceutical Co., Ltd.
中國上海, Dec. 09, 2022 (GLOBE NEWSWIRE) -- 上海愛科百發生物醫藥技術股份有限公司（以下簡稱“ 愛科百發”），一家致力於兒科及呼吸疾病領域創新藥研發的生物製藥企業，今日宣佈中國國家藥品監督管理局正式受理治療呼吸道合胞病毒（RSV）感染新藥愛司韋®（通用名：齊瑞索韋/ziresovir）的上市許可申請（NDA），並且納入“優先審評審批”程式。 ...
Ark Biopharmaceutical Announces NMPA Acceptance and Priority Review of New Drug Application for Ziresovir for Treatment of RSV Infection
December 08, 2022 20:00 ET
|
Shanghai Ark Biopharmaceutical Co., Ltd.
SHANGHAI, China, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Shanghai Ark Biopharmaceutical Co., Ltd. (Ark Biopharmaceutical), a biopharma company dedicated to the discovery and development of drugs for...
AB Science a reçu les premières autorisations règlementaires pour initier une étude clinique confirmatoire de phase 3 avec le masitinib dans le traitement de la maladie d’Alzheimer
October 10, 2022 12:04 ET
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE A REÇU LES PREMIÈRES AUTORISATIONS RÈGLEMENTAIRES POUR INITIER UNE ÉTUDE CLINIQUE CONFIRMATOIRE DE PHASE 3 AVEC LE MASITINIB DANS LE TRAITEMENT DE LA MALADIE...
AB Science receives first agencies authorizations to initiate confirmatory Phase 3 clinical study with masitinib in the treatment of Alzheimer’s disease
October 10, 2022 12:04 ET
|
AB Science
PRESS RELEASE AB SCIENCE RECEIVES FIRST AGENCIES AUTHORIZATIONS TO INITIATE CONFIRMATORY PHASE 3 CLINICAL STUDY WITH MASITINIB IN THE TREATMENT OF ALZHEIMER’S DISEASE Paris, October 10th 2022, 6pm...